论文信息 - Miltefosine: An oral drug for visceral leishmaniasis - 字舞流文

Miltefosine: An oral drug for visceral leishmaniasis

R. Prasad | Ranjeet Kumar | U. Singh | B. P. Jaiswal

[1] J. Nichols,et al. Lem3p Is Essential for the Uptake and Potency of Alkylphosphocholine Drugs, Edelfosine and Miltefosine* , 2003, Journal of Biological Chemistry.

[2] R. Handrick,et al. Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisers. , 2003, Current medicinal chemistry. Anti-cancer agents.

[3] S. Castanys,et al. Leishmania donovani Resistance to Miltefosine Involves a Defective Inward Translocation of the Drug , 2003, Antimicrobial Agents and Chemotherapy.

[4] S. Sundar,et al. Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis , 2003, The Pediatric infectious disease journal.

[5] Shyam Sundar,et al. Oral miltefosine for Indian visceral leishmaniasis. , 2002, The New England journal of medicine.

[6] S. Sundar,et al. Oral Miltefosine for Indian visceral leishmaniasis. N Engl J Med , 2002 .

[7] D. Bora. Epidemiology of visceral leishmaniasis in India. , 1999, The National medical journal of India.

[8] C. Unger,et al. Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice , 1992, Antimicrobial Agents and Chemotherapy.

[9] S. Croft,et al. The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani. , 1987, Biochemical pharmacology.